605 - 130 Brew Street
Port Moody, BC V3H 0E3
Canada
604 370 9520
https://www.havnlife.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Tim Moore | Interim CFO, CEO & Chairman | 126,78k | N/A | 1959 |
Ms. Jenna Pozar | Chief Operations Officer | N/A | N/A | N/A |
Mr. Paul More | Controller | N/A | N/A | N/A |
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is based in Port Moody, Canada.
HAVN Life Sciences Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.